2 news items
Should You Hold Viking Therapeutics in Your Portfolio?
AMGN
LLY
NVO
15 May 24
likely prefer a daily weight loss pill to a weekly injection, thereby having the potential to increase the company's customer base, which
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
to the timing of customer orders. Contract revenue and other income was $2.7 million for the first quarter of 2024, compared with $15.7 million
- Prev
- 1
- Next